Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

3.35 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0000000000192.1832.81160.39165.98548.6330000000
Kosten van de omzet 0.1040.1040.1040.1040.1040.1040.10415.1480.0430.0230.00743.01939.80326.57113.84613.6017.7552.82110.17000
Brutowinst -0.104-0.104-0.104-0.104-0.104-0.104-0.104-15.148-0.043-0.023192.173-10.20820.58839.41434.787-13.601-7.755-2.821-10.17000
Brutowinstmarge 00000000001-0.3110.3410.5970.7150000000
Onderzoek- en ontwikkelingskosten 34.69657.57535.04528.18122.06328.95427.544.90519.85829.63357.81143.01939.80326.57113.84613.6017.7552.8213.4892.4112.8261.444
Algemene en administratieve kosten 12.2212.23111.52812.60413.17212.61512.35911.37612.43712.54213.18811.93911.9018.75914.144.0282.2481.2241.261.3580.8920.928
Verkoop- en marketingkosten -0.104-0.104-0.1040000000000000000000
Verkoop-, algemene en administratieve kosten 12.11612.12711.42412.60413.17212.61512.35911.37612.43712.54213.18811.93911.9018.75914.144.0282.2481.2241.261.3580.8920.928
Overige kosten -23.209000000000000000000000
Bedrijfskosten 46.81269.70246.46940.78535.23541.56939.89916.28132.29542.17570.99954.95851.70435.3327.98617.62910.0034.0454.7493.7693.7182.372
Bedrijfsresultaat -46.916-69.806-46.573-40.785-35.235-41.569-39.899-16.281-32.295-42.175121.181-22.1478.68730.65520.647-17.629-10.003-4.045-4.749-3.769-3.718-2.372
Bedrijfsresultaat ratio 00000000000.631-0.6750.1440.4650.4250000000
Totaal overige inkomsten en kosten netto 6.6376.8687.7587.8647.3036.2995.59114.6251.080.0980.050.0530.0520.0580.0090.0070.010.0570.0940.1370.1640.179
Inkomen voor belasting -40.279-62.938-38.815-32.921-27.932-35.27-34.308-11.899-31.215-42.077121.232-22.0948.73930.71320.656-17.622-9.993-3.988-4.655-3.632-3.554-2.193
Inkomen voor belasting ratio 00000000000.631-0.6730.1450.4650.4250000000
Belastingkosten 0.2430.2310.3490.2210.2510.1970.123-3.8330.12-0.0984.16.17.2000000000
Nettowinst -40.522-63.169-39.164-33.142-28.183-35.467-34.431-8.066-31.335-41.979117.132-28.1941.53930.71320.656-17.622-9.993-3.988-4.655-3.632-3.554-2.193
Nettowinstmarge 00000000000.609-0.8590.0250.4650.4250000000
WPA (Winst Per Aandeel) -0.48-0.75-0.47-0.4-0.34-0.43-0.41-0.097-0.38-0.51.41-0.340.020.370.25-0.22-0.21-0.084-0.098-0.077-0.35-0.22
Verwaterde WPA -0.48-0.75-0.47-0.4-0.34-0.43-0.41-0.097-0.38-0.51.34-0.340.020.340.23-0.22-0.21-0.084-0.098-0.077-0.35-0.22
EBITDA -46.812-69.702-46.469-40.681-35.131-41.569-39.899-16.175-32.252-42.168121.181-22.148.69530.66220.653-17.624-9.999-4.041-4.745-3.765-3.714-2.367
EBITDA ratio 00000000000.631-0.6750.1440.4650.4250000000